Login / Signup

Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.

Alessia BariChiara GerardiEleonora AllocatiAgata PuzzovivoVitaliana De SanctisAlessandra TucciMonica BalzarottiSilvia FranceschettiFrancesco MerliAttilio GuariniGuido GiniCarla Minoia
Published in: Cancers (2022)
Compared to other patients suffering from hematological malignancies, classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) patients have a long life expectancy when in complete remission at the end of first, or sometimes second, line treatments [...].
Keyphrases
  • diffuse large b cell lymphoma
  • hodgkin lymphoma
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • young adults
  • rheumatoid arthritis
  • patient reported outcomes